← Back to Search

Behavioral Intervention

MyPEEPS Mobile for HIV Prevention

N/A

Waitlist Available

Led By Rebecca Schnall, PhD, MPH

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Self-report condomless receptive anal or vaginal penile sex with either a cisgender male or transgender woman (e.g., individual designated or assigned male at birth) in the past year

Between 15 and 19 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3 and 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new way to prevent HIV infection in young transgender men, who are at high risk for the disease. If successful, this could be a life-saving intervention for this vulnerable population.

Who is the study for?

This trial is for young transgender men, including those on the transmasculine spectrum, aged 15-19 who are HIV-negative or unsure of their status. Participants must be able to read English, live in the US, own a smartphone, and have had condomless sex with a cis male or trans woman in the past year.

What is being tested?

The MyPEEPS Mobile intervention is being tested as an innovative mobile technology tool designed to deliver HIV prevention information specifically tailored for high-risk young transgender men.

What are the potential side effects?

Since this trial involves educational information delivered via mobile technology rather than medication or medical procedures, there are no direct physical side effects associated with participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I've had unprotected sex in the past year.

Select...

I am between 15 and 19 years old.

Select...

I was assigned female at birth.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3 and 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3 and 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Condomless Receptive Sex Acts

Secondary study objectives

Change in Partner PrEP use and adherence or viral suppression

Change in self-reported HIV and sexually transmitted infections (STI) testing

Change in self-reported Nonoccupational HIV postexposure prophylaxis (nPEP) and pre-exposure prophylaxis (PrEP) use

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Immediate InterventionExperimental Treatment1 Intervention

Study participants randomized to the intervention arm will have access to the MyPEEPS Mobile application for the first three months of the trial and then the intervention is removed at the 3 month follow-up visit.

Group II: Delayed InterventionExperimental Treatment1 Intervention

Participants randomized to the delayed intervention arm will not have access to MyPEEPS Mobile for the first 3 months of the study and will receive access to the MyPEEPS Mobile App at the 3 month follow-up visit.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

MyPEEPS Mobile

2018

N/A

~770

0 / 3Eligibility criteria met